Celestial Biolabs (BOM:532871) EV-to-EBIT : -59.89 (As of May. 13, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Celestial Biolabs EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Celestial Biolabs's Enterprise Value is ₹165.67 Mil. Celestial Biolabs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-2.77 Mil. Therefore, Celestial Biolabs's EV-to-EBIT for today is -59.89.

The historical rank and industry rank for Celestial Biolabs's EV-to-EBIT or its related term are showing as below:

BOM:532871' s EV-to-EBIT Range Over the Past 10 Years
Min: -68.17 Med: 7.43 Max: 118.49
Current: -59.89

During the past 13 years, the highest EV-to-EBIT of Celestial Biolabs was 118.49. The lowest was -68.17. And the median was 7.43.

BOM:532871's EV-to-EBIT is not ranked
in the Biotechnology industry.
Industry Median: 9.43 vs BOM:532871: -59.89

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Celestial Biolabs's Enterprise Value for the quarter that ended in Dec. 2023 was ₹45.62 Mil. Celestial Biolabs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-2.77 Mil. Celestial Biolabs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -6.06%.

Celestial Biolabs EV-to-EBIT Historical Data

The historical data trend for Celestial Biolabs's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestial Biolabs EV-to-EBIT Chart

Celestial Biolabs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

Get a 7-Day Free Trial

9.97

-0.16

-92.32

-43.72

-28.91

Celestial Biolabs Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-12.40	-38.78	-8.73	-28.91	-16.49

Competitive Comparison of Celestial Biolabs's EV-to-EBIT

For the Biotechnology subindustry, Celestial Biolabs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celestial Biolabs's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celestial Biolabs's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Celestial Biolabs's EV-to-EBIT falls into.

Celestial Biolabs EV-to-EBIT Calculation

Celestial Biolabs's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	165.669	/	-2.766
	=	-59.89

Celestial Biolabs's current Enterprise Value is ₹165.67 Mil.
Celestial Biolabs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-2.77 Mil.

Celestial Biolabs (BOM:532871) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Celestial Biolabs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-2.766	/	45.624326
	=	-6.06 %

Celestial Biolabs's Enterprise Value for the quarter that ended in Dec. 2023 was ₹45.62 Mil.
Celestial Biolabs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-2.77 Mil.

Celestial Biolabs EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Celestial Biolabs's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Celestial Biolabs (BOM:532871) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestial Biolabs Ltd (BOM:532871) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot No. 59, Road No 12, TSIIC Tech Park, IDA Nacharam, Hyderabad, TG, IND, 500076

Website

http://www.celestialbiolabs.com

Celestial Biolabs Ltd is an India based biopharmaceutical company. It is engaged in the business activity producing and supplying of the biotechnological products. The company offers herbal, feed supplement and nutraceutical products. The proprietary herbal products of the group include BIOVITA, CADALMIN GAE, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, BIOPOWER GOLD, BIO-DNORM, DERMACEL, GYNOCEL, HEALTHONE, RELIFIN, and C-KAPS. The organization formulates and manufactures Ayurvedic proprietary products for the Indian market.

Celestial Biolabs (BOM:532871) Headlines

No Headlines